A study published in Health Affairs found that supplemental rebates paid by drug manufacturers to state Medicaid programs grew fivefold between 2017 and 2024. That is a significant shift in how prescription drug costs are negotiated at the government level. While Medicaid and ACA marketplace plans are separate programs, this trend has real implications for anyone shopping for or currently enrolled in a marketplace health plan.
What Are Drug Rebates and Why Do They Matter?
When a drug manufacturer wants its medication covered by an insurance program, it often negotiates a rebate. This is essentially a discount paid back to the insurer or government program after the drug is purchased. The bigger the rebate, the lower the net cost of that drug for the program.
Medicaid programs have become increasingly skilled at negotiating these supplemental rebates on top of the federally required baseline rebates. The fivefold growth seen from 2017 to 2024 shows states are getting much better at this. Private insurers offering ACA marketplace plans watch these trends closely because the same drugs are often covered across both types of plans.
The Connection Between Medicaid Rebates and Marketplace Premiums
You might wonder how a Medicaid rebate affects your ACA plan. The connection is indirect but real. Here is how it works:
- Market pricing pressure: When Medicaid programs secure deep discounts on a drug, it signals to private insurers that lower prices are achievable. This can encourage marketplace insurers to push harder in their own negotiations.
- Formulary decisions: If a drug becomes more affordable through rebate deals, insurers are more likely to place it on preferred tiers of their drug formulary. That means lower copays for you.
- Long-term premium trends: Prescription drug costs are one of the biggest drivers of health insurance premiums. Broader rebate success across all programs can slow premium growth over time.
What This Means When You Are Choosing a Plan
Understanding drug rebate trends can help you make smarter decisions during open enrollment. Here are a few practical things to keep in mind:
- Check the formulary every year. Drug tier placements change annually as insurers renegotiate rebates. A medication that was expensive last year may be in a lower cost tier this year.
- Compare out-of-pocket drug costs across plans. Do not just look at premiums. Use the plan comparison tools on HealthCare.gov to see what you would actually pay for your specific prescriptions.
- Ask about specialty drugs. High-cost specialty medications are often the focus of rebate negotiations. If you take a specialty drug, review each plan carefully to see if it is covered and at what cost.
- Look for plans with integrated pharmacy benefits. Some marketplace plans have tighter coordination between medical and pharmacy coverage, which can reflect stronger rebate arrangements with drug makers.
The Bigger Picture for ACA Enrollees
The growth in Medicaid drug rebates is part of a broader shift toward stronger price negotiation across American healthcare. The Inflation Reduction Act also gave Medicare new authority to negotiate drug prices directly, which adds even more downward pressure on what manufacturers can charge. Over time, these forces working together may help keep ACA marketplace premiums more stable than they would otherwise be.
None of this happens automatically or immediately for marketplace enrollees, but staying informed about how drug pricing works puts you in a better position to choose the right plan for your needs and budget.
Practical takeaway: Before your next open enrollment period, review your current prescriptions and compare them against each available plan's formulary. Small changes in drug tier placement can save you hundreds of dollars per year, and those placements often shift as insurers benefit from improved rebate arrangements.